http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-122342-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bc6d7e07cca0c16f01bcf4a891790c0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
filingDate 2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b8b0f1d94b0e7724d65fb6ae1f157f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d768506ac8ed0854b8febdf6356e1841
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_816ec668c4c4a64b093220df8ed7ee4b
publicationDate 2020-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber UA-122342-C2
titleOfInvention METHOD OF INHIBITING ABSORPTION AND / OR ACCELERATING LIPID EXPRESSION USING D-PSYCOSIS
abstract The present invention relates to a composition for the prevention or treatment of lipid-related metabolic diseases. The composition of the present invention contains D-psychosis as an active ingredient. D-psychosis has the ability to inhibit the absorption of lipids in the small intestine and significantly increases lipid levels in the feces. Due to this ability, D-psychosis is effective in inhibiting the formation of fats in the body. Additionally, D-psychosis reduces body weight, body fat, and plasma lipid levels to normal levels to normalize body weight, body fat, and plasma lipid profiles. Because of these beneficial effects, D-psychosis is expected to be useful for pharmaceuticals, healthy functional foods and functional foods suitable for the prevention and / or treatment of lipid-related metabolic disorders.
priorityDate 2015-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90008

Total number of triples: 15.